Antithrombotic Effects GLP-1 agonists reduce cardiovascular events through several mechanisms previously summarized to include improved glycemic control, weight loss, lowering blood pressure, lipid lowering, reduced atherogenesis, attenuated vascular inflammation, improved endothelial cell function, vasodilation, and direct cardiovascular protective effects [88, 89]
After oral administration, this material targets the colon and specifically binds to Escherichia coli in the gut, releasing ZnPBA nanozymes to eliminate harmful bacteria while simultaneously scavenging reactive oxygen species (ROS) to suppress oxidative stress and inflammatory responses
it reflects the companys role as a chemical supplier rather than a pharmacy or clinic
Trulicity is FDA-approved for promoting glycemic control in patients with type 2 diabetes mellitus and reducing the risk of cardiovascular diseases